Tsg101-GAGp6 interaction and use thereof
US7202329B2 · kind B2 · utility
2Cited by
5References
64Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2001 |
| Grant date | Apr 10, 2007 |
| Priority date | — |
| Expiry date | Oct 4, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16222
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Isolated protein complexes are provided comprising Tsg101 and HIV GAGp6. The protein complexes are useful in screening assays for selecting compounds effective in modulating the Tsg101-HIV GAGp6 interaction within the protein complexes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.